Shattuck Labs Ownership | Who Owns Shattuck Labs?
Shattuck Labs Ownership Summary
Shattuck Labs is owned by 56.24% institutional investors, 14.36% insiders, and 29.40% retail investors. Prosight management, lp is the largest institutional shareholder, holding 13.02% of STTK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.65% of its assets in Shattuck Labs shares.
STTK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Shattuck Labs | 56.24% | 14.36% | 29.40% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Prosight management, lp | 6.64M | 13.02% | $5.26M |
| Redmile group | 5.54M | 10.86% | $4.39M |
| Adage capital partners gp | 4.67M | 9.17% | $3.70M |
| Blackrock | 2.47M | 4.89% | $9.55M |
| Vanguard group | 2.41M | 4.74% | $2.91M |
| Clark estates inc/ny | 1.48M | 2.89% | $1.17M |
| Pinnacle associates | 1.36M | 2.67% | $1.08M |
| 683 capital management | 1.09M | 2.15% | $867.02K |
| Geode capital management | 911.47K | 1.79% | $1.10M |
| Blackrock funding, inc. /de | 881.39K | 1.73% | $697.88K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Takeda pharmaceutical | 515.62K | 2.09% | $408.27K |
| Prosight management, lp | 6.64M | 1.28% | $5.26M |
| Redmile group | 5.54M | 0.47% | $4.39M |
| Clark estates inc/ny | 1.48M | 0.26% | $1.17M |
| 683 capital management | 1.09M | 0.06% | $867.02K |
| Piper sandler | 39.47K | 0.02% | $31.25K |
| Pinnacle associates | 1.36M | 0.02% | $1.08M |
| Adar1 capital management | 102.95K | 0.01% | $81.51K |
| Nverses capital | 3.30K | 0.01% | $12.74K |
| Adage capital partners gp | 4.67M | 0.01% | $3.70M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.47M | 0.00% | 1.94M |
| State street | 710.83K | 0.00% | 554.91K |
| Goldman sachs group | 240.86K | - | 132.20K |
| Y-intercept (hong kong) | 123.17K | 0.00% | 123.17K |
| Morgan stanley | 219.79K | 0.00% | 117.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 6.28K | - | -7.15M |
| Blackrock funding, inc. /de | 881.39K | - | -1.72M |
| Franklin resources | - | - | -1.57M |
| Laurion capital management lp | - | - | -661.04K |
| Renaissance | 28.10K | 0.00% | -222.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 123.17K | 0.00% | 123.17K | $97.53K |
| Point72 asia (singapore) pte. | 28.91K | 0.00% | 28.91K | $22.89K |
| Bnp paribas arbitrage, snc | 7.94K | - | 7.94K | $9.61K |
| Nverses capital | 3.30K | 0.01% | 3.30K | $12.74K |
| Cwm | 533.00 | - | 533.00 | $1.00K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -6.00 |
| Federated hermes | -152.00 |
| Point72 asset management | -200.00 |
| Sterling capital management | -250.00 |
| Coldstream capital management | -321.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 61 | -18.67% | 28,684,223 | -8.03% | 56 | 1.50% | 30 | 20.00% | 21 | -12.50% |
| Mar 31, 2025 | 5 | -93.24% | 12,594,508 | -60.18% | 24 | 0.64% | 2 | -94.87% | 1 | -94.44% |
| Dec 31, 2024 | 21 | -72.73% | 7,490,701 | -79.01% | 14 | 0.30% | 11 | -74.42% | 3 | -83.33% |
| Sep 30, 2024 | 77 | 2.67% | 35,694,485 | 6.30% | 70 | 1.59% | 43 | -17.31% | 18 | 28.57% |
| Jun 30, 2024 | 75 | 2.74% | 33,580,277 | 12.53% | 66 | 1.35% | 52 | 8.33% | 14 | 40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.22M | 4.65% | 12.22K |
| Fidelity Growth Compy Commingled Pl O | 2.21M | 4.63% | - |
| Fidelity Advisor Biotechnology I | 1.32M | 2.76% | - |
| Vanguard US Total Market Shares ETF | 1.31M | 2.74% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.29M | 2.69% | -28.12K |
| Fidelity Growth Company Fund | 1.28M | 2.68% | -2.72K |
| Franklin Biotechnology Discv A(acc)USD | 1.06M | 2.23% | - |
| Fidelity Series Small Cap Opps | 622.74K | 1.30% | - |
| Fidelity Growth Company K6 | 550.52K | 1.15% | -9.50K |
| Franklin Biotechnology Discovery A | 505.80K | 1.06% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $1.01K |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $4.56M |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $3.33M |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $202.23 |
| Aug 25, 2025 | ORBIMED ADVISORS LLC | - | Buy | $16.67M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | 1 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | 3 |
STTK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools